Market Place
Sourcing Support
Once-daily RELEXXII supports ADHD Awareness Month
01 Oct 2024 //
PR NEWSWIRE
Collegium Completes Acquisition of Ironshore Therapeutics
04 Sep 2024 //
GLOBENEWSWIRE
Hi-Tech Increases Adderex® XR Production Capacity
19 Jun 2024 //
PR NEWSWIRE
Enforcement Report - Week of March 29, 2023
29 Mar 2023 //
FDA
Enforcement Report - Week of December 7, 2022
07 Dec 2022 //
FDA
Enforcement Report - Week of July 6, 2022
06 Jul 2022 //
FDA
Enforcement Report - Week Of June 01, 2022
01 Jun 2022 //
FDA
Mylan Tech Viatris` Generic Methylphenidate Receives Approval in the U.S.
14 Mar 2022 //
FDA
Enforcement Report - Week of March 10, 2021
10 Mar 2021 //
FDA
Actavis Elizabeth’s Generic Methylphenidate Receives Approval In US
26 Jun 2020 //
FDA
Adlon Therapeutics and Purdue Pharma L.P. Will Present Data from Adhansia XRâ„¢
16 Jan 2020 //
BUSINESS WIRE
FDA Consults on Abuse-Deterrent CNS Stimulants
20 Sep 2019 //
RAPS
WHO keeps key lung cancer drugs off its essential medicines list
10 Jul 2019 //
REUTERS
FDA Drafts Guidance for Developing Drugs to Treat ADHD
06 May 2019 //
RAPS
Teva and Neos settle over Cotempla patent dispute
28 Dec 2018 //
PHARMAPHORUM
Teva Pharms` Generic Methylphenidate Receives Tentative Approval in US
20 Dec 2018 //
FDA
Ironshore Pharmaceuticals Receives FDA Approval Of Jornay PM For ADHD
10 Aug 2018 //
RDMAG
FTC Approves Merger of Generic Drug Marketers Amneal, Impax
11 Jul 2018 //
FTC GOV
FTC imposes conditions on Amneal acquisition of Impax
11 Jul 2018 //
PHARMA LETTER
ANI Pharmaceuticals Completes Acq.of Generic Products & Assets from Amneal/Impax
07 May 2018 //
PR NEWSWIRE
Enforcement Report - Week of April 25, 2018
25 Apr 2018 //
FDA
Neos Therapeutics Seems To Be Capitalizing On Pfizer`s Decisions
15 Jan 2018 //
SEEKINGALPHA
Pharmascience Inc. Recalls pms-Methylphenidate ER
20 Oct 2017 //
HEALTH CANADA
Enforcement Report - Week of September 27, 2017
28 Sep 2017 //
FDA
Lannett Provides Further Update On Methylphenidate ER Tablets
22 Feb 2017 //
REUTERS
Neos Therapeutics Resubmits ADHD Drug Marketing Application
21 Dec 2016 //
REUTERS
Neos Submits NDA for Amphetamine Extended-Release Liquid Suspension Drug
17 Nov 2016 //
GLOBENEWEWIRE
Does your child really need Ritalin?
11 Sep 2015 //
THE TELEGRAPH
FDA balks on generic Concerta as Mallinckrodt, Actavis meds gobble up market
18 Jun 2015 //
FIERCE PHARMA
Johnson Matthey: Ageing population and generics will drive API biz; Alfa Aesar sale on track
08 Jun 2015 //
IN PHARMA TECHNOLOGIST
Collegium swings for a $75M IPO for its abuse-proof painkiller
01 May 2015 //
FIERCE BIOTECH
Health Canada issues “stronger, clearer” warnings about suicide risks linked to ADHD drugs
03 Apr 2015 //
THE STAR
ADHD Drugs May Increase Risk Of Suicidal Thoughts And Behaviours In Some People; Benefits Still Outweigh Risks
01 Apr 2015 //
HEALTHY CANADIANS
Neos Completes $20.6 mn Financing for Advance its Late-Stage ADHD Product Pipeline
26 Feb 2015 //
PHARMABIZ
